Research map: High Potency Proton Pump Inhibitor Versus Vonoprazan in Helicobacter pylori Triple Therapy

Back to the article

Papers in this map

  1. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection · William D. Chey · 2024 · 393 citations · Cited by this paper
  2. Local Price and Clarithromycin Resistance Shape the Cost of Vonoprazan Triple Therapy for Helicobacter pylori Eradication · Christos Zavos · 2026 · Cites this paper
  3. Long‐Term Effect of Macrolides on Helicobacter pylori Eradication: Data From the European Registry on Helicobacter pylori Management (Hp‐ EuReg ) · 2026 · Related
  4. New concepts of resistance in the treatment of Helicobacter pylori infections · David Yates Graham · 2008 · 359 citations · Cited by this paper
  5. Empirical Rescue Eradication Therapy for Helicobacter pylori Infection in Second and Subsequent Treatment Lines: Experience From 500 Cases of the Brazilian Registry on H. pylori Management (Hp‐ BrazilReg ) · 2025 · Related
  6. Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial · William D. Chey · 2022 · 311 citations · Cited by this paper
  7. A Three‐Way Comparison of Nodular Lesions in H. pylori ‐Induced Gastritis, Non‐ Helicobacter pylori Helicobacter ( NHPH )‐Induced Gastritis, and NHPH ‐Induced MALT Lymphoma Reveals Their Distinct Endoscopic Predictors: Distribution for Bacterial Etiology and Morphology for Malignancy · 2025 · Related
  8. Meta‐analysis: high‐dose proton pump inhibitors vs. standard dose in triple therapy for Helicobacter pylori eradication · Albert Villòria · 2008 · 137 citations · Cited by this paper
  9. Helicobacter pylori and Impaired Early Childhood Development—Evidence From a Birth Cohort Study From Ghana and Côte d'Ivoire · 2025 · Related
  10. Systematic review with meta‐analysis: Vonoprazan, a potent acid blocker, is superior to proton‐pump inhibitors for eradication of clarithromycin‐resistant strains of Helicobacter pylori · Min Li · 2018 · 132 citations · Cited by this paper
  11. Advancing Gastric Cancer Prevention in Korea: Current Strategies and Future Directions · 2026 · Related
  12. Helicobacter pylori Antibiotic Resistance in the United States Between 2011 and 2021: A Systematic Review and Meta-Analysis · Jonathan J. C. Ho · 2022 · 132 citations · Cited by this paper
  13. Different Doses of Ilaprazole for Dual Therapy Versus Bismuth‐Quadruple Therapy for Helicobacter pylori Infection: A Three‐Arm, Randomized Clinical Trial · 2025 · Related
  14. Primer for Development of Guidelines for Helicobacter pylori Therapy Using Antimicrobial Stewardship · David Yates Graham · 2021 · 120 citations · Cited by this paper
  15. Efficacy and Safety of Keverprazan–Amoxicillin Dual Regimen in Initial Eradication of Helicobacter pylori Infection: A Multicenter, Randomized Controlled Trial · 2026 · Related
  16. Relative potency of proton‐pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double‐dose PPI · David Yates Graham · 2018 · 97 citations · Cited by this paper
  17. Hope Hp‐GC Project—Program Implementation for Primary and Secondary Prevention of Gastric Cancer in Latin America · 2026 · Related
  18. AGA Clinical Practice Update on Integrating Potassium-Competitive Acid Blockers Into Clinical Practice: Expert Review · Amit C Patel · 2024 · 87 citations · Cited by this paper
  19. Current Status of Diagnosis, Treatment, and Prevention of Helicobacter pylori Infection in China: A 2024–2025 National Multicenter Cross‐Sectional Study · 2026 · Related
  20. Antimicrobial Susceptibility Testing for Helicobacter pylori Is Now Widely Available: When, How, Why · David Yates Graham · 2022 · 85 citations · Cited by this paper
  21. Efficacy and Safety of Vonoprazan and Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Systematic Review and Meta-Analysis · Wenlin Zhang · 2023 · 33 citations · Cited by this paper
  22. Combinations of antibiotics and vonoprazan for the treatment of Helicobacter pylori infections—Exploratory study · Anoja W. Gunaratne · 2021 · 32 citations · Cited by this paper
  23. Is a Potassium-Competitive Acid Blocker Truly Superior to Proton Pump Inhibitors in Terms of Helicobacter pylori Eradication? · Soichiro Sue · 2021 · 28 citations · Cited by this paper
  24. Update on the first-line treatment of Helicobacter pylori infection in areas with high and low clarithromycin resistances · Chih‐An Shih · 2022 · 23 citations · Cited by this paper
  25. A real‐world exploratory study on the feasibility of vonoprazan and tetracycline dual therapy for the treatment of Helicobacter pylori infection in special populations with penicillin allergy or failed in previous amoxicillin‐containing therapies · Wen Hua Gao · 2023 · 21 citations · Cited by this paper
  26. Efficacy and safety of vonoprazan‐based dual therapy and esomeprazole‐based dual therapy in eradicating primary Helicobacter pylori infection: A propensity score matching analysis · Na‐Yun Su · 2023 · 19 citations · Cited by this paper
  27. Crises in Antimicrobial Stewardship: Misuse of Clarithromycin for Helicobacter pylori Therapy. · David Yates Graham · 2025 · 15 citations · Cited by this paper
  28. Managing Helicobacter pylori as an Infectious Disease: Implementation of Antimicrobial Stewardship · Jen‐Yu Hsu · 2025 · 12 citations · Cited by this paper
  29. Vonoprazan High-Dose Dual, Vonoprazan Triple, and Rabeprazole Reverse Hybrid Therapies for First-Line Treatment of Helicobacter pylori Infection: A Multicenter Randomized Trial · Ping‐I Hsu · 2025 · 6 citations · Cited by this paper
  30. Regarding the AGA Clinical Practice Update on Integrating Vonoprazan Into Clinical Practice · David Yates Graham · 2025 · 4 citations · Cited by this paper
  31. Network meta‐analysis of different dosages of esomeprazole and rabeprazole for the treatment of Helicobacter pylori · Yujiao Wang · 2023 · 3 citations · Cited by this paper
  32. Untitled · Cited by this paper

Source: OpenAlex (CC0)